StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Provision for (benefit from) income taxes by Year

Provision for (benefit from) income taxes — Total ($M) ($M)

Vertex Pharmaceuticals Provision for (benefit from) income taxes: $690M in FY2025, down 12.0% from a year earlier.

Latest, FY2025
690
Period ended Dec 31, 2025
Change on a year earlier
-12.0%
784 in FY2024
History
16 years
Since FY2010
Sources
12
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-Q / 10-K Note (Income Taxes).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedProvision for (benefit from) income taxes — Total ($M) ($M)Year on yearSource
FY2025Dec 31, 2025690-12.0%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 2024784+3.1%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 2023760-16.5%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 2022910+134.5%Form 10-K (filed 2025-02-13) ↗
FY2021Dec 31, 2021388-4.2%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 2020405+85.8%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 2019218-114.7%Form 10-K (filed 2022-02-09) ↗
FY2018Dec 31, 2018-1,487+1,285.7%Form 10-K (filed 2021-02-11) ↗
FY2017Dec 31, 2017-107-742.5%Form 10-K (filed 2020-02-13) ↗
FY2016Dec 31, 201616.7-45.1%Form 10-K (filed 2019-02-13) ↗
FY2015Dec 31, 201530.4+334.3%Form 10-K (filed 2018-02-15) ↗
FY2014Dec 31, 20147-105.7%Form 10-K (filed 2015-02-13) ↗
FY2013Dec 31, 2013-122+40,700.0%Form 10-K (filed 2015-02-13) ↗
FY2012Dec 31, 2012-0.30-101.6%Form 10-K (filed 2015-02-13) ↗
FY2011Dec 31, 201119.3–Form 10-K (filed 2012-02-22) ↗
FY2010Dec 31, 20100–Form 10-K (filed 2011-02-17) ↗

Breakdown

What makes up provision for (benefit from) income taxes

Cite this data

StockData. (2026). Vertex Pharmaceuticals Provision for (benefit from) income taxes ($M), annual FY2010–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/tax-exp-tot

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.